Manchanda, RanjitSun, LiPatel, ShreeyaEvans, OliviaWilschut, JannekeDe Freitas Lopes, Ana CarolinaGaba, FaizaBrentnall, AdamDuffy, StephenCui, BinCoelho De Soarez, PatriciaHusain, ZakirHopper, JohnSadique, ZiaMukhopadhyay, AsimaYang, LiBerkhof, JohannesLegood, Rosa2022-02-112022-02-112020-07-17Manchanda, R, Sun, L, Patel, S, Evans, O, Wilschut, J, De Freitas Lopes, A C, Gaba, F, Brentnall, A, Duffy, S, Cui, B, Coelho De Soarez, P, Husain, Z, Hopper, J, Sadique, Z, Mukhopadhyay, A, Yang, L, Berkhof, J & Legood, R 2020, 'Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems', Cancers, vol. 12, no. 7, 1929. https://doi.org/10.3390/cancers120719292072-6694PubMedCentral: PMC7409094ORCID: /0000-0003-4081-6883/work/108311413https://hdl.handle.net/2164/18053Acknowledgments We are grateful to Melissa Southey (Monash University, Australia) for her support of this work. The study is supported by researchers at the Barts Cancer Research UK Centre for Excellence, Queen Mary University of London (C16420/A18066). This study/analysis received full ethics approval from the Institute of Child Health/ Great Ormond Street Hospital Research Ethics Committee on (REC Reference number 08/H0713/44, Substantial Amendment 3/7/2018). Funding R.L., L.Y. and L.S. are supported by travel costs funded by the Royal Society UK and National Natural Science Foundation of China (7181101283). R.M. is supported through an NHS Innovation Accelerator Fellowship and by The Eve Appeal. A.B. is supported by C569/A16891 grant from Cancer Research UK.5729827engSDG 3 - Good Health and Well-beingBRCApopulation testingcost-effectivenessovarian cancerbreast cancercancer preventionR MedicineOtherCancer Research UKC569/A16891RJournal article10.3390/cancers12071929127